MARKET

AstraZeneca to buy Fusion Pharmaceuticals for up to $2.4 billion



AstraZeneca is buying Fusion Pharmaceuticals for $2.4 billion as the London-listed group looks to build its presence in cutting-edge cancer treatments.


Source link

Related Articles

Please, use our online surveys for check your audience.
Back to top button
pinup